HCPCS Quarterly Update

Quarterly Update for HCPCS Codes

The CMS HCPCS Quarterly Update includes two new codes (Q2048 and Q2049) for liposomal doxorubicin that will become effective July 1, 2012. The code descriptors are worded in a manner that distinguishes Lipodox and Doxil. As of Sun July 1, HCPCS code J9001 – Doxorubicin HCl, all lipid formulations, 10 mg will not be used for Medicare billing. CMS will release a Change Request (CR) with additional instructions in the near future.

Similar Posts

Leave a Reply

Your email address will not be published.